Anyone who's healed from a cut or a scrape has witnessed the incredible regenerative power of stem cells. These cells can create identical copies of ...
“The approval by NICE makes LYTENAVA™ (bevacizumab gamma) the first and only ophthalmic bevacizumab to be available on the NHS and for Independent Sector Providers, which is a stride in the right ...
A research team has discovered that accumulated DNA damage in the retina is a key contributor to age-related macular degeneration and that targeting specific retinal cell types may lead to treatments ...
The National Audit Office (NAO) said current expansion plans are “insufficient to meet future demand” amid a projected shortage of 12,400 prison places by the end of 2027, with costs expected to be at ...